Exploring the role of cancer fatalism and engagement with skin cancer genetic information in diverse primary care patients

Jennifer L. Hay,Yelena Wu,Elizabeth Schofield,Kim Kaphingst,Andrew L. Sussman,Delores D. Guest,Keith Hunley,Yuelin Li,David Buller,Marianne Berwick
DOI: https://doi.org/10.1002/pon.6331
2024-03-30
Psycho-Oncology
Abstract:Objective To broaden the currently limited reach of genomic innovations, research is needed to understand how psychosocial and cultural factors influence reactions to genetic testing in diverse subgroups. Cancer fatalism is important in cancer prevention and deserves theoretical and empirical attention in the context of genomics and behavior change. Methods The current study employed data from a randomized controlled trial (N = 593) offering skin cancer genetic testing (using the melanocortin‐1 receptor [MC1R] gene) in primary care in Albuquerque, New Mexico, USA. We examined interrelations of cancer fatalism with demographics, general health beliefs, perceived risk, perceived control, sun protection and skin screening behaviors and cancer worry in the skin cancer context stratified across Hispanic versus non‐Hispanic ethnicity, and examined cancer fatalism as a moderator of intervention effects on study primary outcomes, including 3‐month sun protection, cancer worry and perceived risk. Results Cancer fatalism was significantly related to the perception of control over skin cancer risk behaviors (ps ≤ 0.01) and demographics (ethnicity, education, health literacy; ps
oncology,social sciences, biomedical,psychology, multidisciplinary
What problem does this paper attempt to address?